Comparison of the Efficacy and Tolerability of Telmisartan and Enalapril in Patients of Mild to Moderate Essential Hypertension

Overview

Journal Indian J Pharmacol

Specialty Pharmacology

Date 2011 Jun 30

PMID 21713052

Citations 2

Authors

Lekha Saha

Affiliations

Soon will be listed here.

Citing Articles

Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.

Li X, Lan Y, Wang Y, Nie M, Lu Y, Zhao E Mol Med Rep. 2017; 15(5):2574-2582.

PMID: 28447738 PMC: 5428554. DOI: 10.3892/mmr.2017.6318.

Authors' reply.

Akat P, Bapat T, Murthy M, Karande V, Burute S Indian J Pharmacol. 2011; 43(3):360-1.

PMID: 21713053 PMC: 3113400.

References

Akat P, Bapat T, Murthy M, Karande V, Burute S . Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension. Indian J Pharmacol. 2010; 42(3):153-6. PMC: 2937316. DOI: 10.4103/0253-7613.66838. View